Novartis CEO said that the pharmaceutical company's strategy involves not exceeding acquisitions of more than $5 billion. The agreement with Cytokinetics meant a larger investment, since,...
Janssen increased its profit to €72.2 million last year. In total, Johnson&Johnson expects year-end revenue to be between $93 billion and $93.5 billion, while it expects...